학술논문

Switch to ritonavir-boosted versus unboosted atazanavir plus raltegravir dual-drug therapy leads to similar efficacy and safety outcomes in clinical practice
Document Type
Article
Author
Gantner, P.Rey, D.Bani-Sadr, F.Garraffo, R.Roger, P.-M.Pugliese, P.Treger, M.Jovelin, T.Allavena, C.Billaud, E.Biron, C.Bonnet, B.Bouchez, S.Boutoille, D.Brunet, C.Jovelin, T.Hall, N.Bernaud, C.Morineau, P.Reliquet, V.Aubry, O.Point, P.Besnier, M.Grossi, O.Lefebvre, M.Hüe, H.Cavellec, M.Soria, A.Pineau, S.André-Garnier, E.Rodallec, A.Brégigeon, S.Faucher, O.Obry-Roguet, V.Orticoni, M.Soavi, M.J.Luquet-Besson, I.Ressiot, E.Pinot, I.Ducassou, M.J.Bertone, H.Gallie, S.Trijau, S.Ritleng, A.S.Ivanova, A.Guignard, M.Blanco-Betancourt, C.Poizot-Martin, I.Alvarez, M.Biezunski, N.Cuzin, L.Debard, A.Delobel, P.Delpierre, C.Fourcade, C.Marchou, B.Martin-Blondel, G.Porte, L.Mularczyk, M.Garipuy, D.Saune, K.Lepain, I.Marcel, M.Puntis, E.Pugliese, P.Ceppi, C.Cua, E.Cottalorda, J.Dellamonica, P.Demonchy, E.Dunais, B.Durant, J.Etienne, C.Ferrando, S.Fuzibet, J.G.Garraffo, R.Risso, K.Mondain, V.Naqvi, A.Oran, N.Perbost, I.Pillet, S.Prouvost-Keller, B.Pradier, C.Wehrlen-Pugliese, S.Rosenthal, E.Sausse, S.Roger, P.M.Choisy, Ph.Vandame, S.Huleux, Th.Ajana, F.Alcaraz, I.Baclet, V.Huleux, T.H.Melliez, H.Viget, N.Valette, M.Aissi, E.Allienne, Ch.Meybeck, A.Riff, B.Agher, R.Katlama, C.Valantin, M.A.Duvivier, C.Joly, V.Yazdanpanah, Y.Landman, R.Mackoumbou-Nkouka, C.Louni, F.Julia, Z.Charpentier, C.Descamps, D.Cotte, L.Peyramond, D.Chidiac, C.Ferry, T.Ader, F.Biron, F.Boibieux, A.Miailhes, P.Perpoint, T.Schlienger, I.Dahoud, F.Lippmann, J.Braun, E.Koffi, J.Longuet, C.Guéripel, V.Augustin-Normand, C.Degroodt, S.Rey, D.Batard, M.L.Bernard-Henry, C.Cheneau, C.De Mautort, E.Fischer, P.Partisani, M.Priester, M.Gantner, P.Bani-Sadr, F.Rouger, C.Berger, J.L.N'Guyen, Y.Lambert, D.Kmiec, I.Hentzien, M.Lebrun, D.
Source
In: PLoS ONE. (PLoS ONE, October 2016, 11(10))
Subject
Language
English
ISSN
19326203